Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Short-Term Debt issuances (2016 - 2020)

Haemonetics (HAE) has 12 years of Short-Term Debt issuances data on record, last reported at -$150.0 million in Q4 2020.

  • For Q4 2020, Short-Term Debt issuances fell 3100.0% year-over-year to -$150.0 million; the TTM value through Oct 2021 reached -$150.0 million, down 236.36%, while the annual FY2021 figure was -$60.0 million, 233.33% down from the prior year.
  • Short-Term Debt issuances reached -$150.0 million in Q4 2020 per HAE's latest filing, down from -$60.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $150.0 million in Q2 2020 and bottomed at -$150.0 million in Q4 2020.
  • Average Short-Term Debt issuances over 5 years is -$3.2 million, with a median of $145000.0 recorded in 2016.
  • Peak YoY movement for Short-Term Debt issuances: plummeted 18300.46% in 2016, then skyrocketed 16204.35% in 2019.
  • A 5-year view of Short-Term Debt issuances shows it stood at -$39.9 million in 2016, then skyrocketed by 100.41% to $162000.0 in 2017, then crashed by 43.21% to $92000.0 in 2018, then skyrocketed by 5334.78% to $5.0 million in 2019, then crashed by 3100.0% to -$150.0 million in 2020.
  • Per Business Quant database, its latest 3 readings for Short-Term Debt issuances were -$150.0 million in Q4 2020, -$60.0 million in Q3 2020, and $150.0 million in Q2 2020.